Azenta, Inc. (LON:0HQ1)

London flag London · Delayed Price · Currency is GBP · Price in USD
46.10
+1.20 (2.66%)
At close: Feb 20, 2025
-27.32%
Market Cap 1.62B
Revenue (ttm) 528.87M
Net Income (ttm) -129.23M
Shares Out n/a
EPS (ttm) -2.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Average Volume 164
Open 46.10
Previous Close 44.91
Day's Range 46.10 - 46.10
52-Week Range 37.18 - 69.06
Beta 1.47
RSI 35.46
Earnings Date Feb 6, 2025

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,... [Read more]

Sector Healthcare
Founded 1978
Employees 3,300
Stock Exchange London Stock Exchange
Ticker Symbol 0HQ1
Full Company Profile

Financial Performance

In 2024, Azenta's revenue was $656.32 million, a decrease of -1.32% compared to the previous year's $665.07 million. Losses were -$164.17 million, 1051.5% more than in 2023.

Financial numbers in USD Financial Statements

News

Azenta, Inc. (AZTA) Q1 2025 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA) Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ETCompany ParticipantsYvonne Perron - Vice President, FP&A &...

17 days ago - Seeking Alpha

Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024

BURLINGTON, Mass. , Feb. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2024.

18 days ago - PRNewsWire

Earnings Scheduled For February 5, 2025

Companies Reporting Before The Bell • Aurora Cannabis (NASDAQ: ACB) is likely to report quarterly loss at $0.03 per share on revenue of $80.01 million. • LiveWire Gr (NYSE: LVWR) is estimated to rep...

18 days ago - Benzinga

Azenta Q1 2025 Earnings Preview

18 days ago - Seeking Alpha

Azenta Inc (AZTA) Reports Q4 Revenue of $150.83M, EPS of -$0.11, Surpassing Estimates

Azenta Inc (AZTA) Reports Q4 Revenue of $150.83M, EPS of -$0.11, Surpassing Estimates

20 days ago - GuruFocus

Azenta Announces the Election of Dipal Doshi to its Board of Directors

BURLINGTON, Mass. , Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader i...

23 days ago - PRNewsWire

Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast

BURLINGTON, Mass. , Jan. 27, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024, on Wednesday February 5, 2025, before t...

26 days ago - PRNewsWire

Azenta: Taking A Pass

Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat tepid growth prospects. Read more here.

27 days ago - Seeking Alpha

UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence

BURLINGTON, Mass. , Jan. 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale samp...

4 weeks ago - PRNewsWire

Azenta Inc (AZTA) Trading Down 3.29% on Dec 5

Azenta Inc (AZTA) Trading Down 3.29% on Dec 5

2 months ago - GuruFocus

Final Trade: BABA, GOOGL, AZTA, GDX

The final trades of the day with the Fast Money traders.

3 months ago - CNBC Television

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

NEW YORK , Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) i...

3 months ago - PRNewsWire

Azenta to Participate in Stephens Annual Investment Conference

BURLINGTON, Mass. , Nov. 14, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 2...

3 months ago - PRNewsWire

Azenta, Inc. (AZTA) Q4 2024 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA) Q4 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Yvonne Perron - Vice President, FP&A and Investor Relations John Marotta - President and ...

3 months ago - Seeking Alpha

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and Multiomics FY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margi...

3 months ago - PRNewsWire

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast

BURLINGTON, Mass. , Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12,...

3 months ago - PRNewsWire

Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

William L. Cornog, Quentin Koffey and Alan J. Malus Add Deep Industry Expertise and Track Records of Shareholder Value Creation to the Board Establishes Value Creation Committee of the Board Comprised...

3 months ago - PRNewsWire

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

BURLINGTON, Mass. , Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications.

4 months ago - PRNewsWire

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. , Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P.

6 months ago - PRNewsWire

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

BURLINGTON, Mass. , Aug. 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniver...

6 months ago - PRNewsWire

Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript

Azenta, Inc. (NASDAQ:AZTA) Q3 2024 Results Conference Call August 6, 2024 4:30 PM ET Company Participants Yvonne Perron - Vice President, FP&A and Investor Relations Steve Schwartz - President and Ch...

7 months ago - Seeking Alpha